Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010.

J. P. Pearson, S. Parikh, R. C. Orlando, N. Johnston, J. Allen, S. P. Tinling, N. Johnston, P. Belafsky, L. F. Arevalo, N. Sharma, D. O. Castell, M. Fox, S. M. Harding, A. H. Morice, Mark G. Watson, M. D. Shields, N. Bateman, W. A. McCallion, M. P. van Wijk, T. G. WenzlP. D. Karkos, Peter C Belafsky

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Gastro-oesophageal reflux disease (GERD) is one of the commonest diseases of Western populations, affecting 20 to 30% of adults. GERD is multifaceted and the classical oesophageal symptoms such as heartburn and regurgitation often overlap with atypical symptoms that impact upon the respiratory system and airways. This is referred to as extra-oesophageal reflux disease (EERD), or laryngopharyngeal reflux (LPR), which manifests as chronic cough, laryngitis, hoarseness, voice disorders and asthma. The 'Reflux and its consequences' conference was held in Hull in 2010 and brought together a multidisciplinary group of experts all with a common interest in the many manifestations of reflux disease to present recent research and clinical progress in GERD and EERD. In particular new techniques for diagnosing reflux were showcased at the conference. Both clinical and non-clinical key opinion leaders were invited to write a review on key areas presented at the `Reflux and its consequences' conference for inclusion in this supplement. Eleven chapters contained in this supplement reflected the sessions of the conference and included discussion of the nature of the refluxate (acid, pepsin, bile acids and non-acid reflux); mechanisms of tissue damage and protection in the oesophagus, laryngopharynx and airways. Clinical conditions with a reflux aetiology including asthma, chronic cough, airway disease, LPR, and paediatric EERD were reviewed. In addition methods for diagnosis of reflux disease and treatment strategies, especially with reference to non-acid reflux, were considered.

Original languageEnglish (US)
Pages (from-to)1-71
Number of pages71
JournalAlimentary pharmacology & therapeutics
Volume33 Suppl 1
StatePublished - Apr 2011

Fingerprint

Esophageal Diseases
Pepsin A
Gastroesophageal Reflux
Lung
Laryngopharyngeal Reflux
Cough
Asthma
Laryngitis
Voice Disorders
Hoarseness
Hypopharynx
Heartburn
Bile Acids and Salts
Respiratory System
Esophagus
UK 21
Pediatrics
Acids
Research
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Review article : reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. / Pearson, J. P.; Parikh, S.; Orlando, R. C.; Johnston, N.; Allen, J.; Tinling, S. P.; Johnston, N.; Belafsky, P.; Arevalo, L. F.; Sharma, N.; Castell, D. O.; Fox, M.; Harding, S. M.; Morice, A. H.; Watson, Mark G.; Shields, M. D.; Bateman, N.; McCallion, W. A.; van Wijk, M. P.; Wenzl, T. G.; Karkos, P. D.; Belafsky, Peter C.

In: Alimentary pharmacology & therapeutics, Vol. 33 Suppl 1, 04.2011, p. 1-71.

Research output: Contribution to journalArticle

Pearson, JP, Parikh, S, Orlando, RC, Johnston, N, Allen, J, Tinling, SP, Johnston, N, Belafsky, P, Arevalo, LF, Sharma, N, Castell, DO, Fox, M, Harding, SM, Morice, AH, Watson, MG, Shields, MD, Bateman, N, McCallion, WA, van Wijk, MP, Wenzl, TG, Karkos, PD & Belafsky, PC 2011, 'Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010.', Alimentary pharmacology & therapeutics, vol. 33 Suppl 1, pp. 1-71.
Pearson, J. P. ; Parikh, S. ; Orlando, R. C. ; Johnston, N. ; Allen, J. ; Tinling, S. P. ; Johnston, N. ; Belafsky, P. ; Arevalo, L. F. ; Sharma, N. ; Castell, D. O. ; Fox, M. ; Harding, S. M. ; Morice, A. H. ; Watson, Mark G. ; Shields, M. D. ; Bateman, N. ; McCallion, W. A. ; van Wijk, M. P. ; Wenzl, T. G. ; Karkos, P. D. ; Belafsky, Peter C. / Review article : reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. In: Alimentary pharmacology & therapeutics. 2011 ; Vol. 33 Suppl 1. pp. 1-71.
@article{bced464db64e4419a1491f3042dc6a03,
title = "Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010.",
abstract = "Gastro-oesophageal reflux disease (GERD) is one of the commonest diseases of Western populations, affecting 20 to 30{\%} of adults. GERD is multifaceted and the classical oesophageal symptoms such as heartburn and regurgitation often overlap with atypical symptoms that impact upon the respiratory system and airways. This is referred to as extra-oesophageal reflux disease (EERD), or laryngopharyngeal reflux (LPR), which manifests as chronic cough, laryngitis, hoarseness, voice disorders and asthma. The 'Reflux and its consequences' conference was held in Hull in 2010 and brought together a multidisciplinary group of experts all with a common interest in the many manifestations of reflux disease to present recent research and clinical progress in GERD and EERD. In particular new techniques for diagnosing reflux were showcased at the conference. Both clinical and non-clinical key opinion leaders were invited to write a review on key areas presented at the `Reflux and its consequences' conference for inclusion in this supplement. Eleven chapters contained in this supplement reflected the sessions of the conference and included discussion of the nature of the refluxate (acid, pepsin, bile acids and non-acid reflux); mechanisms of tissue damage and protection in the oesophagus, laryngopharynx and airways. Clinical conditions with a reflux aetiology including asthma, chronic cough, airway disease, LPR, and paediatric EERD were reviewed. In addition methods for diagnosis of reflux disease and treatment strategies, especially with reference to non-acid reflux, were considered.",
author = "Pearson, {J. P.} and S. Parikh and Orlando, {R. C.} and N. Johnston and J. Allen and Tinling, {S. P.} and N. Johnston and P. Belafsky and Arevalo, {L. F.} and N. Sharma and Castell, {D. O.} and M. Fox and Harding, {S. M.} and Morice, {A. H.} and Watson, {Mark G.} and Shields, {M. D.} and N. Bateman and McCallion, {W. A.} and {van Wijk}, {M. P.} and Wenzl, {T. G.} and Karkos, {P. D.} and Belafsky, {Peter C}",
year = "2011",
month = "4",
language = "English (US)",
volume = "33 Suppl 1",
pages = "1--71",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Review article

T2 - reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010.

AU - Pearson, J. P.

AU - Parikh, S.

AU - Orlando, R. C.

AU - Johnston, N.

AU - Allen, J.

AU - Tinling, S. P.

AU - Johnston, N.

AU - Belafsky, P.

AU - Arevalo, L. F.

AU - Sharma, N.

AU - Castell, D. O.

AU - Fox, M.

AU - Harding, S. M.

AU - Morice, A. H.

AU - Watson, Mark G.

AU - Shields, M. D.

AU - Bateman, N.

AU - McCallion, W. A.

AU - van Wijk, M. P.

AU - Wenzl, T. G.

AU - Karkos, P. D.

AU - Belafsky, Peter C

PY - 2011/4

Y1 - 2011/4

N2 - Gastro-oesophageal reflux disease (GERD) is one of the commonest diseases of Western populations, affecting 20 to 30% of adults. GERD is multifaceted and the classical oesophageal symptoms such as heartburn and regurgitation often overlap with atypical symptoms that impact upon the respiratory system and airways. This is referred to as extra-oesophageal reflux disease (EERD), or laryngopharyngeal reflux (LPR), which manifests as chronic cough, laryngitis, hoarseness, voice disorders and asthma. The 'Reflux and its consequences' conference was held in Hull in 2010 and brought together a multidisciplinary group of experts all with a common interest in the many manifestations of reflux disease to present recent research and clinical progress in GERD and EERD. In particular new techniques for diagnosing reflux were showcased at the conference. Both clinical and non-clinical key opinion leaders were invited to write a review on key areas presented at the `Reflux and its consequences' conference for inclusion in this supplement. Eleven chapters contained in this supplement reflected the sessions of the conference and included discussion of the nature of the refluxate (acid, pepsin, bile acids and non-acid reflux); mechanisms of tissue damage and protection in the oesophagus, laryngopharynx and airways. Clinical conditions with a reflux aetiology including asthma, chronic cough, airway disease, LPR, and paediatric EERD were reviewed. In addition methods for diagnosis of reflux disease and treatment strategies, especially with reference to non-acid reflux, were considered.

AB - Gastro-oesophageal reflux disease (GERD) is one of the commonest diseases of Western populations, affecting 20 to 30% of adults. GERD is multifaceted and the classical oesophageal symptoms such as heartburn and regurgitation often overlap with atypical symptoms that impact upon the respiratory system and airways. This is referred to as extra-oesophageal reflux disease (EERD), or laryngopharyngeal reflux (LPR), which manifests as chronic cough, laryngitis, hoarseness, voice disorders and asthma. The 'Reflux and its consequences' conference was held in Hull in 2010 and brought together a multidisciplinary group of experts all with a common interest in the many manifestations of reflux disease to present recent research and clinical progress in GERD and EERD. In particular new techniques for diagnosing reflux were showcased at the conference. Both clinical and non-clinical key opinion leaders were invited to write a review on key areas presented at the `Reflux and its consequences' conference for inclusion in this supplement. Eleven chapters contained in this supplement reflected the sessions of the conference and included discussion of the nature of the refluxate (acid, pepsin, bile acids and non-acid reflux); mechanisms of tissue damage and protection in the oesophagus, laryngopharynx and airways. Clinical conditions with a reflux aetiology including asthma, chronic cough, airway disease, LPR, and paediatric EERD were reviewed. In addition methods for diagnosis of reflux disease and treatment strategies, especially with reference to non-acid reflux, were considered.

UR - http://www.scopus.com/inward/record.url?scp=79958007520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958007520&partnerID=8YFLogxK

M3 - Article

C2 - 21366630

AN - SCOPUS:79958007520

VL - 33 Suppl 1

SP - 1

EP - 71

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

ER -